The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient- and clinician-directed implementation strategies to improve serious illness communication for high-risk patients with cancer: A cluster-randomized pragmatic trial.
 
Samuel U Takvorian
Stock and Other Ownership Interests - Bluebird Bio (I); Gilead Sciences (I); Johnson & Johnson (I); Merck (I); Novartis (I); Pfizer (I); Pfizer (I); Portola Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca/Merck; Boehringer Ingelheim (I); Genentech; Health Advances; Novartis (I); Novocure (I)
Research Funding - AstraZeneca (I); Lilly (I); Pfizer; Trizell (I)
 
Alicia BW Clifton
No Relationships to Disclose
 
Peter Edward Gabriel
No Relationships to Disclose
 
E. Paul Wileyto
No Relationships to Disclose
 
David A Asch
Employment - VAL Health
Leadership - VAL Health
Stock and Other Ownership Interests - VAL Health
Honoraria - Boehringer Ingelheim; Deloitte; Mars Veterinary Health
Research Funding - United Health Group (Inst)
 
Alison M Buttenheim
No Relationships to Disclose
 
Katharine A. Rendle
Honoraria - MJH Healthcare Holdings, LLC
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca; Pfizer (Inst)
Travel, Accommodations, Expenses - MJH Healthcare Holdings, LLC
 
Rachel C Shelton
No Relationships to Disclose
 
Oluwadamilola Motunrayo Fayanju
Research Funding - Gilead Sciences
 
Susan Ware
No Relationships to Disclose
 
Lynn Mara Schuchter
Consulting or Advisory Role - Incyte
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Stand up to Cancer
 
Pallavi Kumar
Honoraria - AI Therapeutics (I)
Consulting or Advisory Role - Acceleron Pharma (I); Amicus Therapeutics (I); Amylyx (I); Biogen (I); Clene Nanomedicine (I); Sarepta Therapeutics (I)
Research Funding - Acceleron Pharma (I); Amicus Therapeutics (I); Amylyx (I); Biogen (I); ImaginAb (I); Orphazyme (I); Orphazyme (I); Sarepta Therapeutics (I)
Travel, Accommodations, Expenses - Acceleron Pharma (I); Amylyx (I)
 
Lawrence N. Shulman
Consulting or Advisory Role - Genentech
Research Funding - Celgene (Inst); Independence Blue Cross (Inst)
 
Tasnim Salam
No Relationships to Disclose
 
Daniel Ragusano
No Relationships to Disclose
 
Daniel Blumenthal
No Relationships to Disclose
 
Justin E. Bekelman
Stock and Other Ownership Interests - Reimagine Care
Honoraria - National Comprehensive Cancer Network
Consulting or Advisory Role - Reimagine Care; UnitedHealthcare
Research Funding - Loxo@Lilly (Inst)
 
Rinad S Beidas
Honoraria - Optum/UnitedHealth Group
Consulting or Advisory Role - Optum/UnitedHealth Group; OptumLabs
 
Robert Schnoll
No Relationships to Disclose
 
Ravi Bharat Parikh
Stock and Other Ownership Interests - GNS Healthcare; Google; Merck; Onc.AI; Thyme Care
Consulting or Advisory Role - Humana; Merck; NanOlogy; Thyme Care
Research Funding - Humana
Patents, Royalties, Other Intellectual Property - Technology to integrate patient-reported outcomes into electronic health record algorithms
Travel, Accommodations, Expenses - The Oncology Institute of Hope and Innovation